tert-Butyl 2-(3-fluorophenyl)propan-2-ylcarbamate
|
- $134 - $896
- Product name: tert-Butyl 2-(3-fluorophenyl)propan-2-ylcarbamate
- CAS: 689232-63-1
- MF: C14H20FNO2
- MW: 253.31
- EINECS:
- MDL Number:MFCD18378248
- Synonyms:tert-Butyl 2-(3-fluorophenyl)propan-2-ylcarbamate;Carbamic acid, [1-(3-fluorophenyl)-1-methylethyl]-, 1,1-dimethylethyl ester (9CI)
4 prices
Selected condition:
Brand
- aablocks
- Crysdot
Package
- 100mg
- 1g
- Manufactureraablocks
- Product numberAA01F9AZ
- Product descriptiontert-Butyl 2-(3-fluorophenyl)propan-2-ylcarbamate 95%
- Packaging1g
- Price$896
- Updated2026-05-30
- Buy
- Manufactureraablocks
- Product numberAA01F9AZ
- Product descriptiontert-Butyl 2-(3-fluorophenyl)propan-2-ylcarbamate 95%
- Packaging100mg
- Price$134
- Updated2026-05-30
- Buy
- ManufacturerCrysdot
- Product numberCD12042696
- Product descriptiontert-Butyl (2-(3-fluorophenyl)propan-2-yl)carbamate 97%
- Packaging1g
- Price$309
- Updated2026-05-27
- Buy
- ManufacturerCrysdot
- Product numberCD12042696
- Product descriptiontert-Butyl(2-(3-fluorophenyl)propan-2-yl)carbamate 97%
- Packaging1g
- Price$309
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| aablocks | AA01F9AZ | tert-Butyl 2-(3-fluorophenyl)propan-2-ylcarbamate 95% | 1g | $896 | 2026-05-30 | Buy |
| aablocks | AA01F9AZ | tert-Butyl 2-(3-fluorophenyl)propan-2-ylcarbamate 95% | 100mg | $134 | 2026-05-30 | Buy |
| Crysdot | CD12042696 | tert-Butyl (2-(3-fluorophenyl)propan-2-yl)carbamate 97% | 1g | $309 | 2026-05-27 | Buy |
| Crysdot | CD12042696 | tert-Butyl(2-(3-fluorophenyl)propan-2-yl)carbamate 97% | 1g | $309 | 2021-12-16 | Buy |
Properties
Melting point :50-52°
Safety Information
| Symbol(GHS): |
|
|||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Warning | |||||||||||||||||||||||||||||||||||
| Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
| Precautionary statements: |
|




